Kathryn L Fantasia (Kathryn Fantasia)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Interstitial Lung Disease

Ankylosing Spondylitis

Glycemic Control

Top Venues

Journal of diabetes science and technology

Journal of patient experience

Annals of the American Thoracic Society

Journal of the Endocrine Society

This page only lists publications with an associated author ORCID identifier.

Publications

Kayla C Jones, Kirsten Austad, Santana Silver, Erika G Cordova-Ramos, Kathryn L Fantasia, Daisy C Perez, Kristen Kremer, Sophie Wilson, Allan Walkey, Mari-Lynn Drainoni
Patient Perspectives of the Hospital Discharge Process: A Qualitative Study. Journal of patient experience 10 (2023)
Kayla C Jones, Kirsten Austad, Santana Silver, Erika G Cordova-Ramos, Kathryn L Fantasia, Daisy C Perez, Kristen Kremer, Sophie Wilson, Allan Walkey, Mari-Lynn Drainoni
Patient Perspectives of the Hospital Discharge Process: A Qualitative Study. Journal of patient experience 10 (2023)
Kathryn L Fantasia, Lindsay B Demers, Devin W Steenkamp, Katherine L Modzelewski
An Opportunity for Improvement: Evaluation of Diabetes Technology Education Among Adult Endocrinology Training Programs. Journal of diabetes science and technology (2022)
Nicholas A Bosch, Kathryn L Fantasia, Katherine L Modzelewski, Sara M Alexanian, Allan Jay Walkey
Racial Disparities in Guideline-Concordant Insulin Infusions during Critical Illness. Annals of the American Thoracic Society 18 (2) (2021)
Kathryn L Fantasia, Kamonkiat Wirunsawanya, Christopher Lee, Ivania Rizo
Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital. Journal of diabetes science and technology 15 (5) (2021)
Kathryn L Fantasia, Katherine L Modzelewski, Devin Steenkamp
Predictive Glucose Trends From Continuous Glucose Monitoring: Friend or Foe in Clinical Decision Making? Journal of diabetes science and technology 13 (5) (2019)
Kathryn L Fantasia, Devin W Steenkamp
Optimal Glycemic Control in a Patient With HNF1A MODY With GLP-1 RA Monotherapy: Implications for Future Therapy. Journal of the Endocrine Society 3 (12) (2019)